283 related articles for article (PubMed ID: 26530370)
1. CA 19-9: Biochemical and Clinical Aspects.
Scarà S; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():247-60. PubMed ID: 26530370
[TBL] [Abstract][Full Text] [Related]
2. A Case of Pseudoelevation of Serum CA19-9 Level.
Li G; Lu T; Lv S
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213206
[TBL] [Abstract][Full Text] [Related]
3. Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.
Jawad ZAR; Theodorou IG; Jiao LR; Xie F
Sci Rep; 2017 Oct; 7(1):14309. PubMed ID: 29085011
[TBL] [Abstract][Full Text] [Related]
4. Extraordinarily high serum CA 19-9 in setting of pancreatic necrosis and underlying pancreatic adenocarcinoma: a case report.
McConnell A; Stoneman T; Hewlett S
J Surg Case Rep; 2023 Oct; 2023(10):rjad550. PubMed ID: 37846412
[TBL] [Abstract][Full Text] [Related]
5. Dilemma of elevated CA 19-9 in biliary pathology.
Tsen A; Barbara M; Rosenkranz L
Pancreatology; 2018 Dec; 18(8):862-867. PubMed ID: 30249386
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer.
Kamisawa T; Wood LD; Itoi T; Takaori K
Lancet; 2016 Jul; 388(10039):73-85. PubMed ID: 26830752
[TBL] [Abstract][Full Text] [Related]
7. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
[TBL] [Abstract][Full Text] [Related]
8. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.
Chang JC; Kundranda M
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335509
[TBL] [Abstract][Full Text] [Related]
9. Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.
Luo G; Guo M; Jin K; Liu Z; Liu C; Cheng H; Lu Y; Long J; Liu L; Xu J; Ni Q; Yu X
Pancreatology; 2016; 16(6):1057-1062. PubMed ID: 27692554
[TBL] [Abstract][Full Text] [Related]
10. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.
Luo G; Jin K; Deng S; Cheng H; Fan Z; Gong Y; Qian Y; Huang Q; Ni Q; Liu C; Yu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188409. PubMed ID: 32827580
[TBL] [Abstract][Full Text] [Related]
11. Elevation of CA 19-9 in benign processes.
Martín Guerra JM; Martín Asenjo M; Prieto de Paula JM
Med Clin (Barc); 2019 Jul; 153(2):e9-e10. PubMed ID: 30545699
[No Abstract] [Full Text] [Related]
12. Prognostic and predictive markers in pancreatic adenocarcinoma.
Le N; Sund M; Vinci A;
Dig Liver Dis; 2016 Mar; 48(3):223-30. PubMed ID: 26769569
[TBL] [Abstract][Full Text] [Related]
13. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.
Luo G; Fan Z; Cheng H; Jin K; Guo M; Lu Y; Yang C; Fan K; Huang Q; Long J; Liu L; Xu J; Lu R; Ni Q; Warshaw AL; Liu C; Yu X
Pancreatology; 2018 Dec; 18(8):971-976. PubMed ID: 30131287
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency.
Parra-Robert M; Santos VM; Canis SM; Pla XF; Fradera JMA; Porto RM
Anticancer Res; 2018 Oct; 38(10):5883-5888. PubMed ID: 30275214
[TBL] [Abstract][Full Text] [Related]
15. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.
Engle DD; Tiriac H; Rivera KD; Pommier A; Whalen S; Oni TE; Alagesan B; Lee EJ; Yao MA; Lucito MS; Spielman B; Da Silva B; Schoepfer C; Wright K; Creighton B; Afinowicz L; Yu KH; Grützmann R; Aust D; Gimotty PA; Pollard KS; Hruban RH; Goggins MG; Pilarsky C; Park Y; Pappin DJ; Hollingsworth MA; Tuveson DA
Science; 2019 Jun; 364(6446):1156-1162. PubMed ID: 31221853
[TBL] [Abstract][Full Text] [Related]
16. Current and future biomarkers for pancreatic adenocarcinoma.
Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.
Lee T; Teng TZJ; Shelat VG
World J Gastrointest Surg; 2020 Dec; 12(12):468-490. PubMed ID: 33437400
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
[TBL] [Abstract][Full Text] [Related]
19. [CA19-9: more than just a biomarker?].
Ammer-Herrmenau C; Neesse A
Z Gastroenterol; 2020 Jan; 58(1):74-75. PubMed ID: 31931544
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
